Biotechnology News

SYDNEY, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) announces that following formal achievement of database lock in its pivotal XanaMIA trial of oral Xanamem® in...

MILAN and MORRISTOWN, N.J., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel...

DURHAM, N.C., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Scipher Medicine (Scipher), a leader in immunology precision medicine, today announced the expected launch of an early physician access program for...

Neumarker to apply its AI-native brain intelligence platform to advance precision medicine in depression

SAN FRANCISCO, Oct. 28, 2026 (GLOBE NEWSWIRE) -- TCG Labs Soleil, a venture-biotech organization integrating dedicated capital with an in-house R&D hub, today announced significant portfolio...

BOCA RATON, Fla., Oct. 28, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a late-stage biotechnology company focused on inflammation and immunology, today announced that...

BRISBANE, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at...

ROCKAWAY, N.J., Oct. 28, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), (“electroCore” or the “Company”), a bioelectronic technology company, today announced that it has submitted a...

SAN CLEMENTE, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners...

SYDNEY, AUSTRALIA, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage immunotherapy company targeting cancer and autoimmune...